Sunshine Biopharma IncSBFM
Price$0.69

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $36.3M+4.1% YoYTTM through 31 Dec 2025
Net Income -$6MTTM through 31 Dec 2025
Free Cash Flow -$5.3MTTM through 31 Dec 2025

Margins

Current
Gross Margin33.8%
Operating Margin-17.1%
Net Margin-16.5%

Returns

-26.0%ROE
-19.9%ROA

Balance Sheet Health

Debt / Equity0.00x
Net Debt-$9.1Mnet cash position
Cash & Equivalents$9.1M

Quality Metrics

FCF Margin-14.6%
Earnings-Beat Rate0.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Nora Pharma (Generics)$35.2M
View details

Planning to launch at least 12 additional generic products throughout 2026.

Sunshine Canada (OTC Supplements)$1.1M
View details

Develops and sells nonprescription over-the-counter supplements.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.